• 908 Devices Inc. MASS.OQ reported a quarterly adjusted loss of 56 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -23 cents. The mean expectation of five analysts for the quarter was for a loss of 35 cents per share. Wall Street expected results to range from -39 cents to -31 cents per share.

• Revenue rose 31.1% to $18.82 million from a year ago; analysts expected $16.39 million.

• 908 Devices Inc.'s reported EPS for the quarter was a loss of 56 cents​.

• The company reported a quarterly loss of $19.45 million.

• 908 Devices Inc. shares had fallen by 10.0% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for 908 Devices Inc. is $6.00

This summary was machine generated from LSEG data March 4 at 04:56 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)